BCBS Fights Dismissal Bid In Aggrenox Pay-For-Delay Suit
Louisiana Blue Cross/Blue Shield urged a Connecticut federal court Friday not to dismiss the insurer's state antitrust claims from multidistrict litigation accusing Boehringer Ingelheim Pharmaceuticals Inc. of scheming to keep generic...To view the full article, register now.
Already a subscriber? Click here to view full article